Drug May Protect Kids After Stem Cell Transplant MedPage Today Defibrotide prophylaxis lowered the incidence of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Note that patients in the control group who developed veno-occlusive disease were treated with defibrotide, ... |
